MarketSorrento Therapeutics Stock Bearish Momentum With A 16% Slide In The Last 5 SessionsVia News Editorial Team•Apr 13, 2023
MarketSorrento Therapeutics Stock Is 15% Down In The Last 5 SessionsVia News Editorial Team•Apr 6, 2023
MarketSorrento Therapeutics Stock Over 15% Down In The Last 5 SessionsVia News Editorial Team•Apr 5, 2023
MarketSorrento Therapeutics Stock Over 15% Down In The Last 5 SessionsVia News Editorial Team•Apr 4, 2023
MarketSorrento Therapeutics Stock Went Down By Over 21% In The Last 10 SessionsVia News Editorial Team•Mar 31, 2023
MarketSorrento Therapeutics Stock Bearish By 21% In The Last 10 SessionsVia News Editorial Team•Mar 30, 2023
MarketSorrento Therapeutics Stock Over 21% Down In The Last 10 SessionsVia News Editorial Team•Mar 29, 2023
MarketSorrento Therapeutics Stock Bearish Momentum With A 21% Slide In The Last 5 SessionsVia News Editorial Team•Mar 24, 2023
MarketSorrento Therapeutics Stock Over 16% Down In The Last 5 SessionsVia News Editorial Team•Mar 23, 2023
MarketSorrento Therapeutics And Pacific Biosciences Of California On The List Of Winners And Losers Of Tuesday's US SessionVia News Editorial Team•Feb 21, 2023
MarketSorrento Therapeutics Stock Over 13% Up At Session Start On TuesdayVia News Editorial Team•Feb 21, 2023
MarketSorrento Therapeutics Already 9% Down, Almost Six Hours Before The NASDAQ OpenVia News Editorial Team•Feb 21, 2023
MarketSorrento Therapeutics And XP On The List Of Winners And Losers Of Monday's US SessionVia News Editorial Team•Feb 20, 2023
MarketSorrento Therapeutics Stock Impressive Jump 20% At Session Start On Monday, Outperforms MarketVia News Editorial Team•Feb 20, 2023
MarketSorrento Therapeutics Stock Bullish Momentum With A 11.71% Rise Before The WeekendVia News Editorial Team•Feb 17, 2023
MarketPAVmed And XP On The List Of Winners And Losers Of Friday's US SessionVia News Editorial Team•Feb 17, 2023
MarketSorrento Therapeutics Stock Is 12% Up At Session Start TodayVia News Editorial Team•Feb 17, 2023
MarketSorrento Therapeutics And Ringcentral On The List Of Winners And Losers Of Thursday's US SessionVia News Editorial Team•Feb 16, 2023
MarketSorrento Therapeutics Stock Bullish By 33% At Session Start TodayVia News Editorial Team•Feb 16, 2023